US FDA May Start Missing ANDA User Fee Goals – In Order To Speed Approvals

Arrows miss target
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics